These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16652321)

  • 41. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.
    Lucas GM; Chaisson RE; Moore RD
    Ann Intern Med; 1999 Jul; 131(2):81-7. PubMed ID: 10419445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?
    Lucas GM; Flexner CW; Moore RD
    AIDS Patient Care STDS; 2002 Nov; 16(11):527-35. PubMed ID: 12513901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment].
    Pavie J; Porcher R; Fournier S; André F; Tournoux C; Palmer P; Rabian C; Jean-Michel M
    Presse Med; 2005 Jun; 34(10 Suppl):1S8-13. PubMed ID: 16025661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.
    Saber-Tehrani AS; Springer SA; Qiu J; Herme M; Wickersham J; Altice FL
    Contemp Clin Trials; 2012 Mar; 33(2):436-44. PubMed ID: 22101218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts.
    McGowan CC; Weinstein DD; Samenow CP; Stinnette SE; Barkanic G; Rebeiro PF; Sterling TR; Moore RD; Hulgan T
    PLoS One; 2011 Apr; 6(4):e18462. PubMed ID: 21541016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
    Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
    Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
    AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.
    Berg KM; Litwin A; Li X; Heo M; Arnsten JH
    Drug Alcohol Depend; 2011 Jan; 113(2-3):192-9. PubMed ID: 20832196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attitudes toward directly administered antiretroviral therapy (DAART) among HIV-positive inpatients in an inner city public hospital.
    Santos CQ; Adeyemi O; Tenorio AR
    AIDS Care; 2006 Oct; 18(7):808-11. PubMed ID: 16971292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poorer physical health-related quality of life among Aboriginals and injection drug users treated with highly active antiretroviral therapy.
    Martin LJ; Houston S; Yasui Y; Wild TC; Saunders LD
    Can J Public Health; 2012 Nov; 104(1):e33-8. PubMed ID: 23618106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
    Manosuthi W; Sungkanuparph S; Tantanathip P; Lueangniyomkul A; Mankatitham W; Prasithsirskul W; Burapatarawong S; Thongyen S; Likanonsakul S; Thawornwa U; Prommool V; Ruxrungtham K;
    Clin Infect Dis; 2009 Jun; 48(12):1752-9. PubMed ID: 19438397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.
    Springer SA; Chen S; Altice F
    AIDS Care; 2009 Aug; 21(8):976-83. PubMed ID: 20024753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rates of initial virological suppression and subsequent virological failure after initiating highly active antiretroviral therapy: the impact of aboriginal ethnicity and injection drug use.
    Martin LJ; Houston S; Yasui Y; Wild TC; Saunders LD
    Curr HIV Res; 2010 Dec; 8(8):649-58. PubMed ID: 21187007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The feasibility of a community-based directly administered antiretroviral therapy program.
    Wohl AR; Garland WH; Squires K; Witt M; Larsen R; Kovacs A; Hader S; Weidle PJ
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S388-92. PubMed ID: 15156427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.
    Berg KM; Litwin AH; Li X; Heo M; Arnsten JH
    Clin Infect Dis; 2011 Nov; 53(9):936-43. PubMed ID: 21890753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.